All Stories

  1. Incidence and characteristics of engraftment syndrome after autologous hematopoietic cell transplantation in light chain amyloidosis

    Article • Amyloid, July 2019, Taylor & Francis

    Talha Badar

  2. Efficacy of salvage chemotherapy in diffuse large B cell lymphoma with primary treatment failure according to putative cell of origin

    Article • Leukemia & Lymphoma, October 2018, Taylor & Francis

    Talha Badar

  3. Recent advances in understanding and treating immunoglobulin light chain amyloidosis

    Article • F1000Research, August 2018, Faculty of 1000, Ltd.

    Talha Badar

  4. Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma

    Article • European Journal Of Haematology, December 2016, Wiley

    Talha Badar

  5. Outcome of FLT3 ITD Mutated AML Patients Based on Different Treatment Strategies

    Article • June 2015, Elsevier

    Talha Badar

  6. Relapsed Acute Myeloid Leukemia: Need for Innovative Treatment Strategies to Improve Outcome

    Article • June 2015, Elsevier

    Talha Badar

  7. Outcome of Patients with Systemic Light Chain (AL) Amyloidosis with Concurrent Renal and Cardiac Involvement

    Article • Biology of Blood and Marrow Transplantation, February 2015, Elsevier

    Talha Badar

  8. Ibrutinib: a paradigm shift in management of CLL

    Article • Expert Review of Hematology, November 2014, Taylor & Francis

    Talha Badar

  9. Safety and Feasability of Muslim Fasting While Receiving Chemotherapy

    Article • IOSR Journal of Pharmacy (IOSRPHR), January 2014, IOSR Journals

    Talha Badar